Low incidence of COVID‐19 in hidradenitis suppurativa: How to interpret it?

Dear Editor, We read with great interest the publication of Giamarellos-Bourboulis et al.1 that discussed the anti-COVID-19 measurements for hidradenitis suppurativa (HS). The table recapitulates the main characteristics of the patients who developed COVID-19 disease in comparaison to the patients who did not develop COVID-19 disease. Interestingly, the majority of these COVID-19 patients were not treated with systemic therapy for HS and no specific risk factors were identified. [Extracted from the article]